Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Chondroitinase As a Therapeutic Enzyme: Prospects and Challenges Publisher Pubmed



Kheirollahi A1 ; Sadeghi S2 ; Orandi S3 ; Moayedi K3 ; Khajeh K4 ; Khoobi M5, 6 ; Golestani A3
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Comparative Biosciences, Faculty of Veterinary Medicine, University of Tehran, Tehran, Iran
  2. 2. Department of Medical Biotechnology, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran
  3. 3. Department of Clinical Biochemistry, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran
  4. 4. Department of Biochemistry, Faculty of Biological Sciences, Tarbiat Modares University, Tehran, 14115-154, Iran
  5. 5. Department of Radiopharmacy, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
  6. 6. Department of Pharmaceutical Biomaterials and Medical Biomaterials Research Center, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran

Source: Enzyme and Microbial Technology Published:2024


Abstract

The chondroitinases (Chase) are bacterial lyases that specifically digest chondroitin sulfate and/or dermatan sulfate glycosaminoglycans via a β-elimination reaction and generate unsaturated disaccharides. In recent decades, these enzymes have attracted the attention of many researchers due to their potential applications in various aspects of medicine from the treatment of spinal cord injury to use as an analytical tool. In spite of this diverse spectrum, the application of Chase is faced with several limitations and challenges such as thermal instability and lack of a suitable delivery system. In the current review, we address potential therapeutic applications of Chase with emphasis on the challenges ahead. Then, we summarize the latest achievements to overcome the problems by considering the studies carried out in the field of enzyme engineering, drug delivery, and combination-based therapy. © 2023
Experts (# of related papers)
Other Related Docs
12. Calcium and Tnfα Additively Affect the Chondroitinase Abc I Activity, International Journal of Biological Macromolecules (2017)
20. Biomimetic Engineered Approaches for Neural Tissue Engineering: Spinal Cord Injury, Journal of Biomedical Materials Research - Part B Applied Biomaterials (2023)